MedWatch

Mads Krogsgaard is the last of Novo Nordisk's old guard, but he is not ready for retirement

There is still plenty of ambition and gumption left in Mads Krogsgaard Thomsen - the doyen of Novo Nordisk's executive management - and surrounded by a brand new team of VPs he is ready to spearhead the next major breakthroughs in the pharma group's research and development.

Photo: Ritzau Scanpix/Jacob Ehrbahn

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles